Cargando…
Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma
BACKGROUND: Management of locoregional recurrence (LRR) and distant metastasis (DM) in adenoid cystic carcinoma (ACC) is guided by limited data. We investigated mortality risks in patients diagnosed and treated for recurrent ACC. METHODS: A retrospective review of ACC patients treated from 1989 to 2...
Autores principales: | Xu, Melody J., Wu, Tara J., van Zante, Annemieke, El-Sayed, Ivan H., Algazi, Alain P., Ryan, William R., Ha, Patrick K., Yom, Sue S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922301/ https://www.ncbi.nlm.nih.gov/pubmed/29695289 http://dx.doi.org/10.1186/s40463-018-0273-z |
Ejemplares similares
-
Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma
por: Park, Susan, et al.
Publicado: (2020) -
Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck
por: Rodriguez-Russo, Carlos A., et al.
Publicado: (2021) -
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma
por: Lee, Rex H., et al.
Publicado: (2022) -
Fatty Acid Binding Protein 7 Is a Molecular Marker in Adenoid Cystic Carcinoma of the Salivary Glands: Implications for Clinical Significance()()
por: Phuchareon, Janyaporn, et al.
Publicado: (2014) -
c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands()()
por: Phuchareon, Janyaporn, et al.
Publicado: (2014)